Company Filing History:
Years Active: 2016
Title: Ivonne Rubio: Innovator in Immunogenic Polypeptides
Introduction
Ivonne Rubio is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of immunology through her innovative research and development of immunogenic polypeptides. Her work is particularly focused on the creation of vaccines and antibodies that target human papillomavirus.
Latest Patents
Ivonne Rubio holds a patent for an immunogenic polypeptide that comprises a scaffold polypeptide and a L2 polypeptide or a fragment thereof. The invention relates to a structure where the scaffold polypeptide constrains the structure of the L2 polypeptide, enhancing its immunogenic properties. This patent is crucial for the development of vaccines that can effectively combat human papillomavirus.
Career Highlights
Ivonne Rubio is affiliated with the Deutsches Krebsforschungszentrum, a leading cancer research center in Germany. Her work at this institution has allowed her to focus on groundbreaking research that has the potential to improve vaccine efficacy and antibody production.
Collaborations
Throughout her career, Ivonne has collaborated with notable colleagues such as Martin Mueller and Massimo Tommasino. These collaborations have further enriched her research and contributed to advancements in the field of immunology.
Conclusion
Ivonne Rubio's innovative work in immunogenic polypeptides and her dedication to advancing vaccine development highlight her significant role in the scientific community. Her contributions are paving the way for new solutions in the fight against human papillomavirus.